Vithoba Healthcare And Research Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 8.26 Cr
as on 02-11-2024
- Company Age 4 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.05 Cr
as on 02-11-2024
- Revenue 56.27%
(FY 2023)
- Profit 47.09%
(FY 2023)
- Ebitda 47.27%
(FY 2023)
- Net Worth 35.83%
(FY 2023)
- Total Assets 22.11%
(FY 2023)
About Vithoba Healthcare And Research
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.26 Cr.
The company currently has active open charges totaling ₹14.05 Cr.
Kartik Shende, Sudarshan Shende, and Manish Shende serve as directors at the Company.
- CIN/LLPIN
U74999MH2020PTC352125
- Company No.
352125
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNagpur, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vithoba Healthcare And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartik Shende  | Director | 18-Dec-2020 | Current |
| Sudarshan Shende | Director | 18-Dec-2020 | Current |
| Manish Shende | Director | 18-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Vithoba Healthcare And Research.
Vithoba Healthcare And Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.27% increase. The company also saw a substantial improvement in profitability, with a 47.09% increase in profit. The company's net worth Soared by an impressive increase of 35.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vithoba Healthcare And Research?
In 2023, Vithoba Healthcare And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vithoba Industries Private LimitedActive 12 years 9 monthsKartik Shende, Sudarshan Shende and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jul 2023 | ₹2.05 Cr | Open |
Others Creation Date: 04 Apr 2022 | ₹12.00 Cr | Open |
How Many Employees Work at Vithoba Healthcare And Research?
Vithoba Healthcare And Research has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vithoba Healthcare And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vithoba Healthcare And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
